Cepheid Q1 Revenues Rise 24 Percent | GenomeWeb

NEW YORK (GenomeWeb News) — Cepheid said after the close of the market Thursday that its first quarter revenues grew 24 percent year over year, driven primarily by its commercial clinical business.

The Sunnyvale, Calif.-based molecular diagnostics firm reported total revenues of $132.6 million for the quarter ended March 31, up from $106.9 million in the comparable quarter a year ago, and beating average analyst estimates of $125.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.